QDEL

$14.09+0.43%visit website

QuidelOrtho Corp

Market Cap

$966M

Live price × SEC shares (Jul 29, 2026)

Sector

Health Care

Industry

Health Care

Beta (raw)

0.76

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

0.4

TTM to Jun 2026 · revenue

P/B

0.5

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

N/M

TTM to Jun 2026 · negative EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 28, 2025	Q4 FY2025 Dec 28, 2025	Q1 FY2026 Mar 29, 2026	Q2 FY2026 Jun 28, 2026	TTM Jun 28, 2026
Revenue	699,900	723,600	619,800	630,900	2,674,200
Research & development	41,500	45,800	44,900	48,700	180,900
Selling, general & administrative	186,900	194,400	199,300	189,700	770,300
Operating income	(704,800)	(66,300)	(31,800)	(21,800)	(824,700)
Interest expense	46,100	51,000	51,100	54,700	202,900
Pretax income	(756,900)	(112,400)	(79,500)	(81,200)	(1,030,000)
Income tax	(23,900)	18,300	12,300	11,700	18,400
Net income	(733,000)	(130,700)	(91,800)	(92,900)	(1,048,400)
EPS (basic) ($)	(10.78)		(1.35)	(1.36)	(15.43)
EPS (diluted) ($)	(10.78)		(1.35)	(1.36)	(15.43)
Weighted avg. shares (basic)	68,000		68,200	68,300
Weighted avg. shares (diluted)	68,000		68,200	68,300

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 7, 2026, period ended Jun 28, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 17 more quarters, back to Jul 2021, with Tormere Pro.

Corporate Events (8-K)

1 filing in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Nov 3, 2026 accepted 4:09 PM ET	2.02Earnings release5.02Officer / director change	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

54%

W/W +25.1pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-02-13	2026-02-13	Strobeck Matthew	Director	Purchase	10.0K	$23.96	$240K	27.8K	View
2026-02-13	2026-02-13	Busky Joseph M.	Chief Financial Officer	Purchase	3,370	$23.66	$80K	10.3K	View
2026-02-13	2026-02-13	Blaser Brian J.	President and CEO	Purchase	10.5K	$23.59	$249K	40.1K	View